ciclosporine/trehalose (HUC2-007)
/ Huons
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
May 13, 2024
HU007 in Patients With Dry Eye Syndrome
(clinicaltrials.gov)
- P3 | N=328 | Completed | Sponsor: Huons Co., Ltd. | Recruiting ➔ Completed
Head-to-Head • Trial completion • Dry Eye Disease • Ophthalmology
September 12, 2023
Treatment Strategies And Targets For Severe Psoriasis
(IPC-GLS 2023)
- "In clinical practice treatment strategies are not only based on pathophysiological considerations but also on patients' needs and drug availability. Shared-decision making became in important strategy to increase treatment adherence adding to wellbeing as the overarching principle of people-centered health care."
Psoriasis
March 31, 2023
HU007 in Patients With Dry Eye Syndrome
(clinicaltrials.gov)
- P3 | N=328 | Recruiting | Sponsor: Huons Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Head-to-Head • Dry Eye Disease • Ophthalmology
February 24, 2023
HU007 in Patients With Dry Eye Syndrome
(clinicaltrials.gov)
- P3 | N=328 | Not yet recruiting | Sponsor: Huons Co., Ltd.
Head-to-Head • New P3 trial • Dry Eye Disease • Ophthalmology
1 to 4
Of
4
Go to page
1